Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 하헌주 | * |
dc.date.accessioned | 2016-08-28T12:08:25Z | - |
dc.date.available | 2016-08-28T12:08:25Z | - |
dc.date.issued | 2012 | * |
dc.identifier.issn | 0041-1345 | * |
dc.identifier.other | OAK-8806 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/222666 | - |
dc.description.abstract | Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease worldwide. Excess accumulation of extracellular matrix and the epithelial-to-mesenchymal transition contribute to renal fibrosis, which is associated with DKD. The present study examined whether delayed treatment with human umbilical cord blood-derived stem cells (hUCB-SC) showed a therapeutic effect on DKD progression. Experimental diabetes was induced by intraperitoneal injection of streptozotocin (STZ; 50 mg/kg) into 6-week-old male Sprague-Dawley rats. Age-matched control rats received an equivalent volume of sodium citrate buffer alone. At 4 weeks after the STZ injection when diabetic renal injury had developed, hUCB-SC were administered (1 × 10 6 cells/rat) through the tail vein. Four weeks after administering the hUCB-SC, rats were sacrificed and we measured indices of DKD, including urinary protein excretion as well as fibronectin, α-smooth muscle actin (α-SMA), and E-cadherin mRNA, and protein expression. Diabetic rats developed significantly increased urinary protein excretion and renal hypertrophy compared to those in control rats. Renal expression of fibronectin and α-SMA mRNA, and protein were increased significantly in diabetic rats compared to those in the controls. E-cadherin protein expression in diabetic kidneys decreased significantly. Intravenously administered hUCB-SC effectively reduced proteinuria, renal fibronectin, and α-SMA up-regulation, as well as renal E-cadherin down-regulation in diabetic rats without a significant effect on blood glucose. Engrafted hUCB-SC in diabetic kidneys were confirmed by human DNA PKcs. The results demonstrated that delayed treatment with hUCB-SC attenuated the progression of diabetic renal injury. © 2012 Elsevier Inc. | * |
dc.language | English | * |
dc.title | Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury | * |
dc.type | Conference Paper | * |
dc.relation.issue | 4 | * |
dc.relation.volume | 44 | * |
dc.relation.index | SCI | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 1123 | * |
dc.relation.lastpage | 1126 | * |
dc.relation.journaltitle | Transplantation Proceedings | * |
dc.identifier.doi | 10.1016/j.transproceed.2012.03.044 | * |
dc.identifier.wosid | WOS:000304240400085 | * |
dc.identifier.scopusid | 2-s2.0-84860777504 | * |
dc.author.google | Park J.H. | * |
dc.author.google | Park J. | * |
dc.author.google | Hwang S.H. | * |
dc.author.google | Han H. | * |
dc.author.google | Ha H. | * |
dc.contributor.scopusid | 하헌주(7202277106) | * |
dc.date.modifydate | 20240422113229 | * |